Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial fibrillation

a nationwide cohort study

  • Rutherford, Ole-Christian W
  • Jonasson, Christian
  • Ghanima, Waleed
  • Söderdahl, Fabian
  • Halvorsen, Sigrun
European Heart Journal Cardiovascular Pharmacotherapy 6(2):p 75-85, April 2020. | DOI: 10.1093/ehjcvp/pvz086
Copyright © Oxford University Press 2015
View full text|Download PDF